ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) Q3 2024 Earnings

Aug 26Confirmed
Q3 2024
-0.47
-0.14
0.19
0.53

Details

Expected EPS
N/A
Actual EPS
-0.47191223552
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨ImmuneOnco Biopharmaceuticals (Shanghai)⁩ (⁦1541.HK⁩) has reported earnings of ⁦-0.47191223552⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts